ライフサイエンスコーパス: gastric banding

1 rgoing bariatric surgery (gastric bypass and gastric banding).

2 d 21 women underwent laparoscopic adjustable gastric banding).

3 09 who had undergone laparoscopic adjustable gastric banding.

4 ic bypass, sleeve gastrectomy, or adjustable gastric banding.

5 re, and have a surgical procedure other than gastric banding.

6 leeve gastrectomy have a greater effect than gastric banding.

7 d for procedures following failed adjustable gastric banding.

8 s and procedures following failed adjustable gastric banding.

9 een 2005 and 2008 for patients who had prior gastric banding.

10 < 0.001) after gastric bypass but not after gastric banding.

11 leeve gastrectomy and 1 following adjustable gastric banding.

12 mplication rate than laparoscopic adjustable gastric banding.

13 in patients losing equivalent weight through gastric banding.

14 t-operative complications were found involve gastric banding.

15 ic bypass, sleeve gastrectomy, or adjustable gastric banding.

16 d with greater initial weight reduction than gastric banding (2.77 kg/mo).

17 owed by Roux-en-Y gastric bypass (27.6%) and gastric banding (4.4%).

18 .5% (40.7%-54.2%) for patients who underwent gastric banding; 61.6% (56.7%-66.5%), gastric bypass; 68

19 ric bypasses and one laparoscopic adjustable gastric banding--62+/-52 months ago for the control of s

20 my (adjusted RR, 16.6; 95% CI, 4.7-58.4) and gastric banding (adjusted RR, 6.9; 95% CI, 3.1-15.2).

21 ic bypass (RYGB) and laparoscopic adjustable gastric banding (AGB) are 2 of the most commonly perform

22 oux-en-Y gastric bypass (RYGB) or adjustable gastric banding (AGB) in the MarketScan Commercial Claim

23 of this study was to analyze the adjustable gastric banding (AGB) natural history on a national basi

24 e in veterans who underwent RYGB, adjustable gastric banding (AGB), or sleeve gastrectomy (SG).

25 educes body weight (BW) more than adjustable gastric banding (AGB), which does not trigger increased

26 performed as a rescue procedure after failed gastric banding and (2) study trends in the frequency of

27 er, the frequency of reoperations related to gastric banding and associated short-term outcomes are u

28 stablishes an animal model for nonadjustable gastric banding and characterizes the effect of gastric

29 Restrictive procedures such as adjustable gastric banding and gastroplasty were excluded.

30 echniques, including laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypas

31 pass, 15% sleeve gastrectomy, 10% adjustable gastric banding, and 1% other.

32 tion group underwent laparoscopic adjustable gastric banding, and 29 (70.7%) subsequently underwent T

33 Roux-en-Y bypass, 62% (95% CI, 46-79) after gastric banding, and 60% (95% CI, 51-70) after sleeve ga

34 patients, 13% underwent gastric bypass, 19% gastric banding, and 68% vertical-banded gastroplasty.

35 n and laparoscopic), laparoscopic adjustable gastric banding, and biliopancreatic diversion (with or

36 en-Y gastric bypass, laparoscopic adjustable gastric banding, and laparoscopic sleeve gastrectomy.

37 ness of Roux-en-Y gastric bypass, adjustable gastric banding, and most recently sleeve gastrectomy fo

38 Y gastric bypass and laparoscopic adjustable gastric banding, and their effects on weight loss, comor

39 The use of laparoscopic adjustable gastric banding approached one-third (32.1%) of all proc

40 Although laparoscopic gastric banding as a primary treatment of morbid obesity

41 by 2.9% after gastric bypass and 1.9% after gastric banding at latest follow-up (P < 0.001 for both

42 nish citizens who received gastric bypass or gastric banding between January 1, 1997, and December 31

43 These findings suggest that gastric banding causes esophageal outlet obstruction and

44 enomegaly, living-related donor nephrectomy, gastric banding for morbid obesity, partial gastrectomy,

45 of bariatric surgery of sleeve gastrectomy, gastric banding, gastric bypass with Roux loop confirmed

46 Bariatric surgery (adjustable gastric banding, gastric bypass, and sleeve gastrectomy)

47 secondary procedure after failed adjustable gastric banding (group 2).

48 Laparoscopic adjustable gastric banding has been demonstrated to permit importan

49 rgoing gastric bypass procedure after failed gastric banding have more adverse outcomes than those un

50 estrictive operations, especially adjustable gastric banding, have a lower risk but are somewhat less

51 Complications after laparoscopic adjustable gastric banding include stomal stenosis, malpositioned b

52 The number of reoperations after gastric banding is rapidly increasing in the United Stat

53 Laparoscopic adjustable silicone gastric banding is under evaluation by the Food & Drug A

54 +/- 6.7 kg/m(2)) or laparoscopic adjustable gastric banding (LAGB) (n = 10, BMI 46.5 +/- 8.8 kg/m(2)

55 ric bypass (RYGB) or laparoscopic adjustable gastric banding (LAGB) are not well described.

56 ight loss induced by laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass (RYGB

57 Eight studies of laparoscopic adjustable gastric banding (LAGB) reported data on 352 patients (me

58 gastrectomy (LSG) or laparoscopic adjustable gastric banding (LAGB) were included in the study.

59 stric bypass (RYGB), laparoscopic adjustable gastric banding (LAGB), and an intensive lifestyle weigh

60 ric bypass (RYGB) or laparoscopic adjustable gastric banding (LAGB), we assessed percent weight chang

61 those who underwent laparoscopic adjustable gastric banding (LAGB).

62 (LRYGB) after failed laparoscopic adjustable gastric banding (LAGB).

63 ges before and after laparoscopic adjustable gastric banding (LAGB).

64 ric bypass [RYGB] or laparoscopic adjustable gastric banding [LAGB]) followed by low-level lifestyle

65 Patients who underwent laparoscopic gastric banding lost less weight (change in BMI, 6.4 +/-

66 4-59] years; 2817 men [66.9%]), 265 received gastric banding (median [IQR] age, 55 [46-61] years; 199

67 The 2 most common procedures, adjustable gastric banding (n = 109) and gastric bypass (n = 109),

68 Procedures included laparoscopic gastric banding (n=1053), gastric bypass (795), and slee

69 surgery (Roux-en-Y gastric bypass, n = 162; gastric banding, n = 32; sleeve gastrectomy, n = 23), a

70 o bariatric surgery (laparoscopic adjustable gastric banding; n = 30).

71 tric banding and characterizes the effect of gastric banding on esophageal physiology.

72 RYGB, sleeve gastrectomy, or gastric banding or referral to the MOVE!

73 s who underwent RYGB, sleeve gastrectomy, or gastric banding or who were referred to MOVE!, a weight

74 compared with those who underwent adjustable gastric banding (OR, 8.37 [95% CI, 7.44-9.43]; OR, 21.43

75 derwent sleeve gastrectomy and 16% following gastric banding (P<0.0001).

76 e gastrectomy, and 50% of patients following gastric banding (P=0.004).

77 The number of reoperations after failed gastric banding rapidly increased in the United States d

78 Adjustable gastric banding represented the most common bariatric pr

79 (95% CI, 0.12-11.49) for gastric bypass and gastric banding, respectively.

80 d 1071 patients receiving gastric bypass and gastric banding, respectively.

81 3 (95% CI, 0.08-3.56) for gastric bypass and gastric banding, respectively.

82 3 (95% CI, 0.40-3.75) for gastric bypass and gastric banding, respectively.

83 Nonadjustable gastric banding results in impaired esophageal body moti

84 tric surgery, stratified by type of surgery (gastric banding, Roux-en-Y gastric bypass, sleeve gastre

85 The broad indication for gastric banding should be reaffirmed for the US populati

86 r bariatric procedures (mainly gastroplasty, gastric banding, sleeve gastrectomy, and biliopancreatic

87 Surgical management (gastric banding, sleeve gastrectomy, and Roux-en Y gastr

88 eveloped bariatric surgery models, including gastric banding, sleeve gastrectomy, Roux-en-Y gastric b

89 The gastric banding subset was composed of 800 (74.7%) women

90 t common reason for revision with adjustable gastric banding surgery.

91 ranges from 49% for laparoscopic adjustable gastric banding to 76% for Roux-en-Y gastric bypass.

92 The use of gastric banding to treat obesity has increased drastical

93 Y gastric bypass and laparoscopic adjustable gastric banding-to treat T2DM in severely obese patients

94 f psoriasis and psoriatic arthritis, whereas gastric banding was not.

95 patients undergoing either gastric bypass or gastric banding were followed up for 36 months.

96 vertical sleeve gastrectomy, and adjustable gastric banding were performed in 66%, 28%, and 6% of pa

97 ctive treatment for diabetes than adjustable gastric banding within 6 to 12 months.